Terms: = Lymphoma AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148 AND Treatment
14 results:
1. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
2. A computational in silico approach to predict high-risk coding and non-coding SNPs of human plcg1 gene.
Khan SM; Faisal AM; Nila TA; Binti NN; Hosen MI; Shekhar HU
PLoS One; 2021; 16(11):e0260054. PubMed ID: 34793541
[TBL] [Abstract] [Full Text] [Related]
3. Sensitization to Drug treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
[TBL] [Abstract] [Full Text] [Related]
4. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract] [Full Text] [Related]
5. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract] [Full Text] [Related]
6. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
Ajorloo F; Vaezi M; Saadat A; Safaee SR; Gharib B; Ghanei M; Siadat SD; Vaziri F; Fateh A; Pazhouhandeh M; Vaziri B; Moazemi R; Mahboudi F; Rahimi Jamnani F
PLoS One; 2017; 12(9):e0183969. PubMed ID: 28892521
[TBL] [Abstract] [Full Text] [Related]
7. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
Watanabe T
Blood; 2017 Mar; 129(9):1071-1081. PubMed ID: 28115366
[TBL] [Abstract] [Full Text] [Related]
8. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival.
Zhong W; Yi Q; Xu B; Li S; Wang T; Liu F; Zhu B; Hoffmann PR; Ji G; Lei P; Li G; Li J; Li J; Olkkonen VM; Yan D
Nat Commun; 2016 Sep; 7():12702. PubMed ID: 27581363
[TBL] [Abstract] [Full Text] [Related]
9. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract] [Full Text] [Related]
10. Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.
Woollard WJ; Pullabhatla V; Lorenc A; Patel VM; Butler RM; Bayega A; Begum N; Bakr F; Dedhia K; Fisher J; Aguilar-Duran S; Flanagan C; Ghasemi AA; Hoffmann RM; Castillo-Mosquera N; Nuttall EA; Paul A; Roberts CA; Solomonidis EG; Tarrant R; Yoxall A; Beyers CZ; Ferreira S; Tosi I; Simpson MA; de Rinaldis E; Mitchell TJ; Whittaker SJ
Blood; 2016 Jun; 127(26):3387-97. PubMed ID: 27121473
[TBL] [Abstract] [Full Text] [Related]
11. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.
Kiel MJ; Sahasrabuddhe AA; Rolland DCM; Velusamy T; Chung F; Schaller M; Bailey NG; Betz BL; Miranda RN; Porcu P; Byrd JC; Medeiros LJ; Kunkel SL; Bahler DW; Lim MS; Elenitoba-Johnson KSJ
Nat Commun; 2015 Sep; 6():8470. PubMed ID: 26415585
[TBL] [Abstract] [Full Text] [Related]
12. plcg1 mutations in cutaneous T-cell lymphomas.
Vaqué JP; Gómez-López G; Monsálvez V; Varela I; Martínez N; Pérez C; Domínguez O; Graña O; Rodríguez-Peralto JL; Rodríguez-Pinilla SM; González-Vela C; Rubio-Camarillo M; Martín-Sánchez E; Pisano DG; Papadavid E; Papadaki T; Requena L; García-Marco JA; Méndez M; Provencio M; Hospital M; Suárez-Massa D; Postigo C; San Segundo D; López-Hoyos M; Ortiz-Romero PL; Piris MA; Sánchez-Beato M
Blood; 2014 Mar; 123(13):2034-43. PubMed ID: 24497536
[TBL] [Abstract] [Full Text] [Related]
13. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas.
Balasubramanian S; Ramos J; Luo W; Sirisawad M; Verner E; Buggy JJ
Leukemia; 2008 May; 22(5):1026-34. PubMed ID: 18256683
[TBL] [Abstract] [Full Text] [Related]
14. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis.
Ye K
Cancer Biol Ther; 2005 Sep; 4(9):918-23. PubMed ID: 16103750
[TBL] [Abstract] [Full Text] [Related]